Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

A new patch can deliver stable antibodies over time for potential HIV treatment.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

More precise, personalized therapies are needed for autoimmune diseases.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

PRS injections can improve knee function and reduce pain for up to a year.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Kerion cases had longer disease duration but responded well to antifungal treatments.

Early diagnosis of Keratosis pilaris atrophicans faciei can lead to better, personalized treatments.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

The serum improves facial skin quality safely and effectively.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

Tofacitinib may help regrow hair in alopecia areata patients.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

People with chronic hives should be tested for thyroid autoimmunity to manage their condition better.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.